Host Response to Myeloma: Effect of Syngeneic Spleen Cells on the Growth and Functionof MOPC 104E Myeloma in Vitro

References

• Ghanta V K, Hiramoto R N, Davis D W, Hiramoto N S. Maintenance of MOPC 104E myeloma in plateau phase. Cancer Res 1980; 40: 2372–2376
   PubMed Web of Science ®Google Scholar
• Hellstrom K E, Hellstrom I. Cellular immunity against tumor antigens. Adv Cancer Res 1969; 12: 167–223
   PubMedGoogle Scholar
• Kaliss N. The elements of immunologic enhancement: a consideration of mechanisms. Ann NY Acad Sci 1962; 101: 64–79
   Web of Science ®Google Scholar
• Sjogren H O, Hellstrom I, Bansal S C, Hellstrom K E. Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes. Proc Natl Acad Sci (USA) 1971; 68: 1372–1375
   PubMed Web of Science ®Google Scholar
• Hutchin P, Amos D B, Prioleau W H. Interaction of humoral antibodies and immune lymphocytes. Transplantation 1967; 5: 68–75
   Google Scholar
• Ilfeld D, Carnaud C, Cohen I R, Trainin N. In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro. Int J Cancer 1973; 12: 213–222
   PubMed Web of Science ®Google Scholar
• Irvin G L, Eustace V C. The enhancement and rejection of tumor allografts by immune lymphnode cells. Transplantation 1970; 10: 555–557
   PubMed Web of Science ®Google Scholar
• Abbas A K. T-lymphocyte-mediated suppression of myeloma function in vitro. I. Suppression by allogeneically activated T-lymphocytes. J Immunol 1979; 123: 2011–2018
   PubMed Web of Science ®Google Scholar
• Flood P M, Phillips C, Taupier M A, Schreiber H. Regulation of myeloma growth in vitro by idiotype-specific T-lymphocytes. J Immunol 1980; 124: 424–430
   PubMed Web of Science ®Google Scholar
• Rohrer J W, Odermatt B, Lynch R G. Idiotype-specific suppression on MOPC-315 IgA secretion in vivo: reversible blockade of secretory myeloma cells by soluble mediators. J Immunol 1978; 121: 1799–1807
   PubMed Web of Science ®Google Scholar
• Rohrer J W, Vasa K, Lynch R G. Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: Evidence for repetitive cycles of differentiation. J Immunol 1977; 119: 861–866
   PubMed Web of Science ®Google Scholar
• Daley M. Intratumor maturational heterogeneity within the murine myeloma MOPC-315. Cancer Res 1981; 41: 187–191
   PubMed Web of Science ®Google Scholar
• Lynch R G, Rohrer J W, Odermatt B, Gebel H M, Autry J R, Hoover R G. Immunoregulation of murine myeloma cell growth and differentiation: A monoclonal model of B-cell differentiation. Immunol Rev 1979; 48: 45–80
   PubMed Web of Science ®Google Scholar
• Rosenstreich D L, Blake J T, Rosenthal A S. The peritoneal exudate lymphocyte. I. Differences in antigen responsiveness between peritoneal exudate and lymph node lymphocytes from immunized guinea pig. J Exp Med 1971; 134: 1170–1186
   PubMed Web of Science ®Google Scholar
• Miura T, Hiramoto R N, Ghanta V K. MOPC 104E plasmacytoma functional heterogeneity and maturational potential in culture. Cancer Res 1983; 43: 953–958
   PubMed Web of Science ®Google Scholar
• Jerne N K, Nordin A A. Plaque formation in agar by a single antibody producing cell. Science 1963; 140: 405
   Web of Science ®Google Scholar
• Crissman H A, Steinkamp J A. Rapid, simultaneous measurement of DNA, protein and cell volume in single cells from large mammalian cell populations. J Cell Biol 1973; 59: 766–771
   PubMed Web of Science ®Google Scholar
• Dean P N. Amplified method of DNA distribution analysis. Cell Tissue Kinet 1980; 13: 299–308
   PubMedGoogle Scholar
• Rich S S, Rich R R. Regulatory mechanism in cell-mediated immune responses. II. A genetically restricted suppressor of mixed lymphocyte reactions released by allo-antigen-activated cells. J Exp Med 1975; 142: 1391–1402
   PubMed Web of Science ®Google Scholar
• Swain S, Dutton R W. Negative allogeneic effects in vitro. I. Allogeneic T-cells markedly suppress the secondary antibody forming cell response. J Immunol 1977; 118: 2262–2268
   PubMed Web of Science ®Google Scholar
• Tse H Y, Dutton R W. Separation of helper and suppressor T-lymphocytes. III. Positive and negative effects of mixed lymphocyte reaction-activated T-cells. J Immunol 1978; 120: 1149–1152
   PubMed Web of Science ®Google Scholar
• Miura T, Ghanta V K, Hiramoto R N. Host response to myeloma I. Induction of cytotoxic and suppression T cells by in vivo immunization with MOPC 104E plasmacytoma. Cancer Invest 1988; 6: 29–37
   PubMed Web of Science ®Google Scholar
• Kirchner H, Chused T M, Herberman R B, Holden H T, Lavrin D H. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Maloney sarcoma virus. J Exp Med 1974; 139: 1473–1487
   PubMed Web of Science ®Google Scholar
• Parkhouse R ME, Dutton R W. Inhibition of spleen cell DNA synthesis by autologous macrophages. J Immunol 1966; 97: 663–669
   PubMed Web of Science ®Google Scholar
• Pels E, Otter W D. Natural cytotoxic macrophages in the peritoneal cavity of mice. Br J Cancer 1979; 40: 856–861
   PubMed Web of Science ®Google Scholar
• Namba Y, Hanaoka M. Immunocytology of cultured IgM-forming cells of mouse. I. Requirement of phagocytic cell factor for the growth of IgM-forming tumor cells in tissue culture. J Immunol 1962; 109: 1193–1200
   Google Scholar
• Prehn R T. The immune reaction as a stimulator of tumor growth. Science 1972; 176: 170–171
   PubMed Web of Science ®Google Scholar
• Shrestha K, Hiramoto R N, Ghanta V K. Regulation of MOPC 104E by T cells and growth factors induced by C. parvum stimulation. Int J Cancer 1984; 33: 845–880
   PubMed Web of Science ®Google Scholar
• Prehn R T. Perspectives on oncogenesis: Does immunity stimulate or inhibit neoplasia?. J Reticuloendothel Soc 1971; 10: 1–16
   PubMedGoogle Scholar
• Prehn R T, Lappe M A. An immunostimulation therapy of tumor development. Transplant Rev 1971; 7: 26–54
   PubMedGoogle Scholar
• Small M, Trainin N. Separation of population of sensitized lymphoid cells into fractions inhibiting and fractions enhancing syngeneic tumor growth in vivo. J Immunol 1976; 117: 292–297
   PubMed Web of Science ®Google Scholar